Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04861649Not ApplicableUnknown

Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition

Role: lead

NCT04336462Not ApplicableUnknown

Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19

Role: lead

NCT02850185Not ApplicableUnknown

Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer

Role: lead

NCT04000451Not ApplicableCompleted

A Therapy for Improving Symptoms in Patients With Acute Exacerbations of COPD by Hydrogen-Oxygen Generator With Neburlizer.

Role: lead

NCT02883582Not ApplicableUnknown

Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer

Role: lead

All 5 trials loaded